• Johnson & Johnson unit DePuy Synthes agreed to acquire selective rights to develop, make, market MinMaxMedical’s Gemtrack RF tracking technology.
• Deal targets joint reconstruction navigation and robotics, aiming to remove line-of-sight constraints tied to infrared camera-based tracking.
• Scope covers the Joints portfolio, including shoulder, hip, knee, with planned integration into the VELYS enabling technology ecosystem.
• Closing and rollout depend on product development milestones plus regulatory approvals; no financial terms were disclosed.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Johnson & Johnson published the original content used to generate this news brief on May 26, 2026, and is solely responsible for the information contained therein.